|
ALT Altimmune Inc 1326190 |
| Balance Sheet |
|
Current Assets
|
$334,815,000.00 |
|
Assets
|
$527,212,000.00 |
|
Current Liabilities
|
$12,501,000.00 |
|
Liabilities
|
$53,004,000.00 |
|
Equity
|
$474,208,000.00 |
|
Shares Out
|
194474154.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-45,163,000.00 |
|
Investing Cash Flow
|
$-225,133,000.00 |
| Market Analysis |
Market Cap
|
$573,698,754.30 |
|
Price
|
$2.95 |
|
BVPS
|
2.44 |
|
PB
|
1.21 |
|
EPS
|
-0.12 |
|
PS
|
13992.65 |
|
FCF
|
$-45,216,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:39 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:30 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-0.27 |
|
|
2026-05-13 |
-0.18 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.27 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.21 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALT documents filed with the SEC.
ALT Filings
Clear
